Glass House Brands announced that its subordinate voting shares have been approved for listing on the New York Stock Exchange. The shares are expected to begin trading under the symbol GLAS at the opening on June 30, 2026. The company noted that the uplist was made possible by the recent reclassification of medical cannabis to Schedule III. Glass House will continue to trade on the OTCQX under GLASF until the close of market on June 29, and will remain listed on the CBOE under GLAS.A.U. CEO Kyle Kazan said the listing represents an important milestone for the company and the cannabis industry, and highlighted potential opportunities from rescheduling including interstate commerce and export to Europe.
Glass House Brands Inc.Uplist to NYSE enabled by Schedule III reclassification, a regulatory change.